Citrate Exposures
dc.contributor.advisor | Utidjian, Levon |
dc.contributor.author | Dickinson, Kimberly |
dc.contributor.other | Children's Hospital of Philadelphia |
dc.date.accessioned | 2024-06-10T19:03:14Z |
dc.date.available | 2024-06-10T19:03:14Z |
dc.date.created | 2021-05-12 |
dc.description | This medication concept set includes the ingredients trisodium citrate, sodium citrate, and potassium citrate, and all of their descendants. Combinations are included. It was developed by taking the RxNorm descendants of 19065826 (trisodium citrate), 977968 (sodium citrate), and 976545 (potassium citrate) and excluding the search terms "cream", "ointment", "buccal", "topical", "duralock", "ophthalmic", "glucose", "dextromethorphan", "injectable". This concept set was intended to investigate medication usage of patients with primary hyperoxaluria (PH) before and after diagnosis of PH, specifically for management of kidney stones. It was intended to contain non-topical and non-IV formulations of trisodium citrate, sodium citrate, and potassium citrate. This concept set contains only RxNorm and RxNorm Extension codes. |
dc.description.abstract | Concept set intended to identify patients with an exposure to a citric acid compound. |
dc.identifier.uri | https://pedsnet.org/metadata/handle/20.500.14642/421 |
dc.provenance | A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (PHYOX2) (Dicerna) |
dc.publisher | PEDSnet |
dc.rights | a CC-BY Attribution 4.0 License. |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.subject | Concept Set Development::Content Data Model::PEDSnet Data Model |
dc.subject | Concept Set Development::Concept Set Development Strategy::Variable Characterization::Independent Variable |
dc.subject | Concept Set Development::Concept Set Evaluation::Clinician Reviewed |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Precise Ingredient |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Multiple Ingredients |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Ingredient |
dc.subject.mesh | Citrates |
dc.subject.mesh | Tricarboxylic Acids |
dc.subject.mesh | Acids, Acyclic |
dc.subject.mesh | Carboxylic Acids |
dc.subject.other | RxNorm |
dc.subject.other | RxNorm Extension |
dc.title | Citrate Exposures |
dspace.entity.type | ConceptSet |
local.quality.status | Research-Ready |
local.subject.flat | PEDSnet Data Model |
local.subject.flat | Independent Variable |
local.subject.flat | Clinician Reviewed |
local.subject.flat | Brand Pack Name |
local.subject.flat | Semantic Branded Drug |
local.subject.flat | Semantic Branded Drug Form |
local.subject.flat | Semantic Branded Drug Component |
local.subject.flat | Semantic Clinical Drug |
local.subject.flat | Semantic Clinical Drug Form |
local.subject.flat | Semantic Clinical Drug Component |
local.subject.flat | Precise Ingredient |
local.subject.flat | Multiple Ingredients |
local.subject.flat | Ingredient |
relation.isStudyOfConceptSet | ab3f6341-360e-4f51-bba7-aec268702213 |
relation.isStudyOfConceptSet.latestForDiscovery | ab3f6341-360e-4f51-bba7-aec268702213 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- rx_2021_05_CitrateExposures_V1.csv
- Size:
- 324.86 KB
- Format:
- Comma-Separated Values